IQVIA Guide on RWD Applications in Drug Development Pipeline

May 11, 2021

IQVIA has released an eBook detailing when it’s appropriate to use real world evidence (RWE) and real world data (RWD). RWE integration offers researchers key benefits such as reduced costs and more efficient clinical trials. However, knowing when to utilize such data remains a challenge. The eBook comments on the value of both internal and external sources of RWD, as well as example applications of RWD.

“Do you and your stakeholders truly know when, where, why, and how RWD can be leveraged throughout the drug development lifecycle? This interactive eBook highlights various sources of RWD in the United States, including what types of patient-level data they contain, and what questions they are best-suited to answer. Case examples are included that describe how RWD and analytic methods were utilized to answer key client questions spanning multiple therapeutic areas such as oncology, autoimmune diseases, migraines, etc.” Download the book here.

(Source: IQVIA, 2021)

Share This Story!